Processing

(Image: Getty/mthipsorn)

Takeda secures Shire bid for $62.11bn

By Melissa Fassbender

Takeda has acquired Shire for approximately $62.11bn (£46bn) to create a Japan-headquartered biopharmaceutical company with a robust pipeline and expanded geographical footprint.

GettyImages/f11photo

CPHI NORTH AMERICA 2018

CPhI North America: Live updates from Philadelphia

By Flora Southey

We have arrived in Philadelphia to report on the major trends at CPhI North America including continuous manufacturing, cell and gene therapies, and the changing nature of contract service relationships.

(Image: Getty/sborisov)

INTERPHEX 2018

INTERPHEX 2018: Live updates from the Big Apple

By Flora Southey

INTERPHEX 2018 has kicked off in New York City, and we are here reporting on all things drug formulation, ingredient manufacturing, and contract partnerships for commercial production.